retatrutide dosing in clinical trials safety A new clinical trial from Eli Lilly and Company suggests its experimental Retatrutide dose schedule: complete week-by-week
Description
The exact amount of semaglutide in breast milk has not been formally studied in lactating women because GLP-1 medications were not tested in breastfeeding populations during their clinical trials
[DOI] [PMC free article] [PubMed] [Google Scholar] 93.Athauda D., et al
Kirkpatrick wasnt involved in the study
update policies, controls, and training
Practical implications For patients who develop allodynia on one GLP-1 medication, switching to a different medication within the class (or to a different formulation of the same medication) is a reasonable strategy to try
Int J Pharm 647:123549
